Articles tagged with Lung Cancer
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A Wistar Institute-led team will develop blood tests to detect early lung cancer using proteomics and genomics, aiming to save lives through earlier cancer detection. The project receives $3.4M in funding from Pennsylvania's share of the national tobacco settlement.
A study found that gefitinib is effective for patients with non-small cell lung cancer who are female, never smoked, and have a specific type of cancer. The researchers identified two key factors associated with sensitivity to the drug: having adenocarcinoma with bronchioloalveolar features and never having smoked.
Researchers found that retinoblastoma survivors are at higher risk of epithelial cancers such as esophagus, stomach, colon, lung, breast, cervix, or prostate, despite low radiation therapy. High folate intake is associated with a lower risk of ovarian cancer, especially among women who consume alcohol.
A new theory by Steven Frank proposes that cancer progression speeds up with age, leading to increased incidence in older adults. As people age, fewer stages remain before cancer develops, resulting in higher cancer rates.
A team of researchers has developed a novel lung cancer treatment using nanoparticle cluster bombs, which have shown promise in treating cancerous lung cells. The new delivery system could potentially be used to target cancer cells while leaving healthy cells alone.
A recent study found that reducing cigarette consumption by 25%, 50%, and 75% did not proportionally decrease the levels of carcinogens in smokers' urine. Despite a reduction in cigarettes smoked per day, NNK metabolites remained relatively stable. The authors suggest that people may compensate for reduced smoking by inhaling longer an...
A Phase II trial of Herceptin combined with chemotherapy found no significant difference in survival times between the treatment and control arms. However, a small subgroup of patients with extremely high levels of HER2 over-expression showed improved response rates and longer disease progression-free periods.
The University Hospitals of Cleveland is using GE's RapidScreen Digital to improve lung cancer detection rates. The CAD system analyzes digital x-ray data and draws circles around suspicious regions, focusing radiologists on potential abnormalities.
A recent study published by the Radiological Society of North America (RSNA) found that female smokers are twice as likely to develop lung cancer as male smokers, regardless of smoking habits, age, or nodule size. The study also revealed that increased smoking and aging significantly increase the risk of developing lung cancer.
A study of annual CT screenings found that 80% of diagnosed Stage I lung cancers were curable. Long-term follow-up showed a high cure rate for patients with screen-diagnosed lung cancer who underwent surgery. The findings support the use of widespread annual low-dose CT screening in high-risk smokers to detect early-stage lung cancer.
A new study reveals that residents of Appalachia experience a disproportionate increase in cancer incidence, particularly lung, colon, rectum, and cervix cancers. The study found that rural residents had even higher rates of these cancers compared to the general population.
A new blood test detects mesothelioma at an early stage, potentially leading to improved patient outcomes. The test uses soluble mesothelin-related proteins (SMR) as a biomarker, which can detect the cancer several years before symptoms appear.
A Phase I study for non-small cell lung cancer used stereotactic radioablation, increasing radiation doses without prohibitive toxicity. 87% of patients showed positive tumor response, with no local recurrence at the highest dose levels.
A recent study found that people who underwent lung cancer screening were motivated to quit smoking. The study suggests that cancer screening may present an opportunity for health-care providers to offer smoking cessation resources.
Gefinitib, a designer drug targeting the epidermal growth factor receptor, has shown efficacy in treating advanced non-small cell lung cancer. In a phase II clinical trial, 43% of patients experienced symptom improvement and 12% showed partial radiographic responses.
A new study by Georgetown University Medical Center researchers found that low-dose CT screenings can accelerate smoking cessation rates by 14%, significantly higher than the national average. This promising finding suggests it's never too late to treat nicotine dependence, and further research may lead to more effective interventions.
A study by Temple University researchers identifies the molecular mechanisms that may assist the tumor-suppressing gene Rb2/p130 in blocking lung cancer cells. The study reveals nearly 70 genes regulated by Rb2, including previously known and unknown targets involved in lung cancer progression.
Researcher Dr. Mitra has developed an optical tomography method to locate lung tumors using short-pulse lasers. The technique yields physiological information with higher resolution and a safer system than traditional methods.
A study found that nearly 40% of lung cancer patients believe exposure to air during surgery promotes cancer spread, leading some to reject recommended surgery. The study suggests that physicians need to address these misconceptions to improve healthcare outcomes in African Americans, who are disproportionately affected by lung cancer.
The SARS epidemic taught four important lessons: the need for global cooperation, improved public health infrastructure, care for patients despite personal risk, and measures to minimize infectious risks to healthcare workers. The response to SARS demonstrates that a strong public health infrastructure can help contain outbreaks and pr...
A new trial found a significant survival benefit from adjuvant chemotherapy in non-small cell lung cancer, increasing patient lifespan by 4.1%. The study suggests that toxicity is still a major concern and calls for better tools to identify patients who will benefit from treatment.
Researchers at Duke University Medical Center have developed a new blood test that can detect lung cancer in its earliest stages using MALDI-TOF MS. The test targets serum amyloid A, a protein elevated in lung cancer patients' blood.
A study by Harvard and Queensland universities found that 4.8 million deaths in 2000 were caused by smoking, affecting both developed and developing countries. The majority of these deaths were among men, especially in less-developed nations.
A study published in The Journal of Nuclear Medicine found that 18F-FLT PET scans are more accurate than 18F-FDG PET scans in differentiating between cancerous and non-cancerous lung tumors. However, the researchers noted that 18F-FDG is still a reliable tool for staging tumors.
Measuring DNA repair enzyme OGG activity found a significant association with lung cancer risk. Smokers and nonsmokers with low OGG activity had higher lung cancer risk compared to those with normal activity levels, with smokers being at greater risk due to smoking alone.
A new blood test can detect smokers with low levels of DNA repair enzyme OGG1, which increases their risk of lung cancer by 5-10 times. The test may help inform smoking cessation decisions for high-risk individuals.
Researchers found that a combination of low-dose spiral CT and selective use of PET can effectively detect early-stage lung cancer in high-risk individuals. The study showed that lesions up to 5mm can be safely followed up after 12 months without major risks of progression.
A new study has found that a weekly regimen of paclitaxel and carboplatin is well-tolerated and effective in treating advanced non-small cell lung cancer. The treatment resulted in a response rate of 32% and median survival time of 49 weeks, with fewer side effects compared to standard regimens.
The EU's Europe Against Cancer Programme has shown promising results in reducing cancer deaths across most European countries. However, tobacco use still poses a significant threat to public health, with many countries experiencing declining trends in cancer death rates while others struggle with rising rates.
A study found a strong correlation between genetic polymorphisms in two genes and lung cancer risk in smokers. Mutations in both XPD and cyclin D1 (CCND1) occurred more often in lung cancer patients, increasing the risk of lung cancer among individuals with a smoking history.
Researchers found that the p53 gene plays a crucial role in distinguishing which lung cancer patients are most likely to survive four years or more. The study identified a sub-group of early-stage lung cancer patients without p53 mutations who had a significantly higher survival rate, providing hope for a new treatment approach.
The US Preventive Services Task Force recommends against use of beta-carotene supplements for cancer or cardiovascular disease prevention due to lack of benefit and potential harm. Lawsuits involving human subjects research are increasing, leading to more careful research and increased costs, according to experts.
A study found that PET-CT scans were more accurate than PET scans alone in staging non-small cell lung cancer patients. The combined imaging technique correctly identified lung cancer with chest wall and vascular spread, downgrading tumor severity in 13.3% of cases.
A new study suggests that the area where carcinogens settle may play a key role in developing lung cancer. The research found that cells located at carinal ridges can receive massive doses of toxic particulate matter, potentially leading to impaired mucociliary clearance and increased risk of neoplastic lesions.
The study found that BAC proliferation correlated with HER2 but not EGFR expression, suggesting a potential role for combination therapies. Researchers hope to launch a clinical trial of HER2- and EGFR-blocker combination therapy in the treatment of BAC.
Researchers at Cedars-Sinai Medical Center developed a molecular test that identified a panel of genes correlating with tumor response to gefitinib, a drug approved for shrinking tumors in advanced lung cancer. The study found distinct patterns of gene expression linked to patient responses or lack thereof.
A combination of bevacizumab and erlotinib has shown a 21 percent response rate in patients with recurrent stage IIIb or IV lung cancer, with five patients experiencing partial responses and tumor stabilization for over a year. The treatment was well-tolerated with mild to moderate toxicity.
A new radiotherapy strategy, hyperfractionated accelerated radiotherapy (HART), has been shown to improve survival rates for lung cancer patients. In a phase III multi-site study, chemotherapy followed by HART resulted in a median survival of 21 months, compared to 12 months with standard radiation therapy.
Researchers found that gefitinib can slow lung cancer tumor recurrence when used as maintenance therapy following chemotherapy. The study suggests that gefitinib may keep cancer cells dormant for a period of time.
A study by Chandra P. Belani and colleagues found that elderly patients with advanced NSCLC can tolerate combination therapy safely and effectively, with median survival rates comparable to those of younger patients. The treatment regimens used in the study were weekly paclitaxel in combination with full doses of carboplatin.
In a Phase II clinical trial, C225 and docetaxel combination achieved a 25.5% tumor shrinkage rate in advanced non-small cell lung cancer patients, significantly higher than the median response rate of 5-10%. The results are encouraging and suggest further development of this treatment approach.
A new randomized study found that beta-carotene supplementation increased cancer risk in smokers and drinkers, while decreasing risk in non-smokers and non-drinkers. The study's findings highlight the complexity of designing safe and effective chemopreventive strategies for any cancer.
Researchers treated 18 patients with lung nodules using radiofrequency ablation, achieving a 97% destruction rate. The treatment was found to be short-lasting and manageable, with most complications resolved within a week.
The Stanford study found that FDG-PET is highly effective for lung nodule diagnosis but most cost-effective when used selectively with CT scans. The researchers recommend relying on CT as the initial test for almost all patients and using FDG-PET in cases where the risk of cancer conflicts with CT results.
A study found a nearly two-fold increased risk of lung cancer among relatives of smokers, but no evidence of an increased risk among relatives of non-smokers. The researcher hopes to identify high-risk subgroups and develop tailored interventions or screening programs.
A Duke team has identified two proteins, MIF and CyP-A, that are elevated in lung cancer cells but not in normal cells. These proteins may be potential targets for new therapies and a simple blood test to diagnose lung cancer without biopsies.
The discovery of KCNK9 reveals a significant role in the development of breast and lung cancers. The study found that overexpression of KCNK9 promotes tumor formation in controlled functional tests.
Research on STI571 and paclitaxel shows potential in controlling prostate cancer metastasis to bone. Lung cancer risk varies widely among smokers, with accurate prediction models helping individuals decide on screening. Non-BRCA mutations may be linked to high breast cancer risk in younger women.
Researchers at Memorial Sloan-Kettering Cancer Center developed a mathematical model predicting lung cancer risk based on age, sex, and smoking history. The tool helps balance the risks and benefits of screening for high-risk individuals.
The Prostate Cancer Series assesses the epidemiology of prostate cancer, highlighting the impact of genetic and environmental risk factors. Despite progress in understanding diet-related risks, familial clustering, and ethnic variation remain poorly understood, presenting opportunities for further research.
A Phase III randomized trial found that a combination of vinorelbine and gemcitabine did not improve overall and progression-free survival in elderly NSCLC patients. However, the study suggests that certain chemotherapy combinations, particularly cisplatin-based regimens, may be more effective than single-agent therapy. The results als...
According to a study by Fred Pampel, measures of gender equality do not explain the gap between men's and women's lung-cancer death rates. The gap is best explained historically, with women's smoking following men's on the upswing after a typical lag of around three decades.
A new vaccine technique has shown promise in boosting the natural immune response to tumors in patients with advanced non-small cell lung cancer. The vaccine was found to be non-toxic and well-tolerated, with some patients remaining disease-free for over three years after vaccination.
Researchers found that a vitamin A derivative, 9-cis retinoic acid, increased RAR-_ gene expression and reduced precancerous lesions in former smokers. While promising, the treatment also showed side effects, and further studies are needed to determine its effectiveness.
A recent study found that annual whole-body CT scanning for lung cancer screening may not be effective in saving lives, as the costs outweigh the benefits. The researchers estimated that only smokers who started quitting at age 55-65 saw significant cost-effectiveness in screening.
Breast cancer patients with HER-2/neu overexpression have lower hormone receptor levels, affecting treatment response. HFE gene mutations increase colon cancer risk in the US population.
Research reveals nicotine activates Akt survival pathway, undermining programmed cell death in lung cancer cells. This finding may lead to re-evaluation of quitting-aids' benefits.
Researchers found that nicotine stimulates lung epithelial cells to activate a molecular pathway promoting cell growth and survival. This activation undermines the body's natural defense mechanism against cancer. The study suggests reconsidering the risk-benefit ratio of nicotine-based quitting aids.
Researchers investigated the association between alcohol consumption and lung cancer risk, finding no statistically significant link. The Journal of National Cancer Institute also published studies on body surface area-based dosing for anticancer drugs and carbohydrate binding protein's potential to inhibit tumor growth.
The CALGB 9741 study found significant improvements in disease-free survival and overall survival for women with axillary node-positive operable breast cancer treated with dose-dense chemotherapy regimens. The study showed a 26% proportional reduction in risk of recurrence and improved quality of life with dose-dense therapy.